🚩 On the watch list, its certificate can't be verified in its own name.
Receptorchem openly does its testing 'in-house', i.e. the company selling the product also writes the certificate that says the product is good. There is no outside check anywhere in that loop; the purity figure is whatever they decide to print. Calling that a 'Certificate of Analysis' borrows the authority of independent testing while removing the one thing that gives it meaning, independence.
The certificate, and what's wrong with it
🚩 self-made / in-house
What this certificate actually is: This is a self-issued certificate with only the seller's branding (BioRegen/Receptor Chem) and no independent lab verification., client field: Receptor Chem
⏳ This certificate is dated Nov 2022, about 3 years old. A certificate from Nov 2022 cannot describe anything this seller would ship you today, that batch is long gone. Showing a about 3 years old certificate for a product on sale now is meaningless; the stock you'd actually receive is untested.
Pricing vs the market, benchmarked on BPC-157
The Peptide Watch benchmarks every vendor on the same compound, BPC-157, the most common research peptide, as £ per milligram, so prices are directly comparable across all providers. No public BPC-157 price feed was available for this vendor at audit.
The audit checklist
Check
Result
Verifiable certificate in its own name
No
Independent lab named
None named / unverifiable
Tests its own stock
No evidence
The bottom line. Receptorchem sits on the watch list because it does not publish a certificate that can be verified in its own name. Everything above is observable on its own website and the public record. See the vendors whose certificates are actually their own →
⚠️ Is anything on this page wrong or out of date? Submit a correction request and we'll look into it, vendors welcome too.